| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
|
JAMA
|
2013
|
3.06
|
|
2
|
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
|
Lancet Infect Dis
|
2013
|
1.95
|
|
3
|
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.
|
PLoS Med
|
2010
|
1.81
|
|
4
|
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
|
J Infect Dis
|
2013
|
1.70
|
|
5
|
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.
|
Vaccine
|
2005
|
1.52
|
|
6
|
Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging.
|
BMC Public Health
|
2004
|
1.49
|
|
7
|
Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs.
|
Vaccine
|
2007
|
1.40
|
|
8
|
Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes.
|
CMAJ
|
2014
|
1.24
|
|
9
|
Influenza vaccination: a call for a multiple intervention approach.
|
Can J Public Health
|
2006
|
1.06
|
|
10
|
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals.
|
PLoS One
|
2013
|
1.05
|
|
11
|
Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.
|
Clin Vaccine Immunol
|
2011
|
1.03
|
|
12
|
Risk factors for influenza among health care workers during 2009 pandemic, Toronto, Ontario, Canada.
|
Emerg Infect Dis
|
2013
|
0.98
|
|
13
|
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.
|
BMC Public Health
|
2014
|
0.96
|
|
14
|
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
|
Pediatr Infect Dis J
|
2009
|
0.92
|
|
15
|
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults.
|
Vaccine
|
2012
|
0.90
|
|
16
|
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines.
|
Influenza Other Respir Viruses
|
2014
|
0.90
|
|
17
|
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
|
Vaccine
|
2012
|
0.90
|
|
18
|
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.
|
Vaccine
|
2005
|
0.89
|
|
19
|
Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.
|
BMC Res Notes
|
2010
|
0.89
|
|
20
|
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.
|
Vaccine
|
2012
|
0.88
|
|
21
|
Influenza vaccination and fetal and neonatal outcomes.
|
Expert Rev Vaccines
|
2013
|
0.87
|
|
22
|
An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.
|
Can J Public Health
|
2011
|
0.86
|
|
23
|
Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy.
|
Vaccine
|
2010
|
0.86
|
|
24
|
Influenza vaccine programs and pregnancy: a need for more evidence.
|
J Obstet Gynaecol Can
|
2004
|
0.84
|
|
25
|
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine.
|
BMC Infect Dis
|
2012
|
0.84
|
|
26
|
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose.
|
Vaccine
|
2011
|
0.84
|
|
27
|
Setting priorities for new vaccination programs by using public health officers and immunization managers opinions.
|
Vaccine
|
2008
|
0.83
|
|
28
|
Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial.
|
Pediatr Infect Dis J
|
2012
|
0.79
|
|
29
|
Pharmacists as immunizers: a survey of community pharmacists' willingness to administer adult immunizations.
|
Int J Clin Pharm
|
2015
|
0.78
|
|
30
|
Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine.
|
PLoS One
|
2012
|
0.78
|
|
31
|
Efficacy and Safety of CVT-E002, a Proprietary Extract of Panax quinquefolius in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial.
|
Influenza Res Treat
|
2011
|
0.77
|
|
32
|
Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic.
|
Hum Vaccin Immunother
|
2014
|
0.77
|
|
33
|
Splenectomy: reducing the risk of infection.
|
CMAJ
|
2012
|
0.75
|
|
34
|
Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs.
|
Hum Vaccin
|
2011
|
0.75
|
|
35
|
Influenza vaccination and decisional conflict among regulated and unregulated direct nursing care providers in long-term-care homes.
|
AAOHN J
|
2008
|
0.75
|